These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

467 related articles for article (PubMed ID: 27105596)

  • 1. Current and future alternative therapies for beta-thalassemia major.
    de Dreuzy E; Bhukhai K; Leboulch P; Payen E
    Biomed J; 2016 Feb; 39(1):24-38. PubMed ID: 27105596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta-thalassemia.
    Cao A; Galanello R
    Genet Med; 2010 Feb; 12(2):61-76. PubMed ID: 20098328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of β-globin mutations on outcome of matched related donor hematopoietic stem cell transplantation for patients with β-thalassemia major.
    Hamidieh AA; Saber T; Fayyazi S; Jalali A; Behfar M; Hamdi A; Ghavamzadeh A
    Biol Blood Marrow Transplant; 2014 Nov; 20(11):1772-6. PubMed ID: 25017762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. β-Thalassemia.
    Origa R
    Genet Med; 2017 Jun; 19(6):609-619. PubMed ID: 27811859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent Progress in Gene Therapy and Other Targeted Therapeutic Approaches for Beta Thalassemia.
    Hamed EM; Meabed MH; Aly UF; Hussein RRS
    Curr Drug Targets; 2019; 20(16):1603-1623. PubMed ID: 31362654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current status of beta-thalassemia and its treatment strategies.
    Ali S; Mumtaz S; Shakir HA; Khan M; Tahir HM; Mumtaz S; Mughal TA; Hassan A; Kazmi SAR; Sadia ; Irfan M; Khan MA
    Mol Genet Genomic Med; 2021 Dec; 9(12):e1788. PubMed ID: 34738740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transplantation for thalassemia major: alternative donors.
    Locatelli F; Merli P; Strocchio L
    Curr Opin Hematol; 2016 Nov; 23(6):515-523. PubMed ID: 27537474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CRISPR/Cas-based gene editing in therapeutic strategies for beta-thalassemia.
    Zeng S; Lei S; Qu C; Wang Y; Teng S; Huang P
    Hum Genet; 2023 Dec; 142(12):1677-1703. PubMed ID: 37878144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Innovative Curative Treatment of Beta Thalassemia: Cost-Efficacy Analysis of Gene Therapy Versus Allogenic Hematopoietic Stem-Cell Transplantation.
    Coquerelle S; Ghardallou M; Rais S; Taupin P; Touzot F; Boquet L; Blanche S; Benaouadi S; Brice T; Tuchmann-Durand C; Ribeil JA; Magrin E; Lissillour E; Rochaix L; Cavazzana M; Durand-Zaleski I
    Hum Gene Ther; 2019 Jun; 30(6):753-761. PubMed ID: 30700149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel therapies in β-thalassaemia.
    Grech L; Borg K; Borg J
    Br J Clin Pharmacol; 2022 Jun; 88(6):2509-2524. PubMed ID: 34004015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [γ-Globin Inductive Therapy of β-thalassemia and Its Relationship with MicroRNA].
    Li YY; Gu J; Yu DN
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Apr; 24(2):627-31. PubMed ID: 27151042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hematopoietic stem cell transplantation for people with ß-thalassaemia major.
    Jagannath VA; Fedorowicz Z; Al Hajeri A; Sharma A
    Cochrane Database Syst Rev; 2014 Oct; (10):CD008708. PubMed ID: 25316103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infusion of autologous retrodifferentiated stem cells into patients with beta-thalassemia.
    Abuljadayel IS; Quereshi H; Ahsan T; Rizvi S; Ahmed T; Khan SM; Akhtar J; Dhoot G
    ScientificWorldJournal; 2006 Oct; 6():1278-97. PubMed ID: 17041717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta-thalassemia.
    Galanello R; Origa R
    Orphanet J Rare Dis; 2010 May; 5():11. PubMed ID: 20492708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hematopoietic stem cell transplantation for people with β-thalassaemia.
    Sharma A; Jagannath VA; Puri L
    Cochrane Database Syst Rev; 2021 Apr; 4(4):CD008708. PubMed ID: 33880750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemoglobin disorders: lentiviral gene therapy in the starting blocks to enter clinical practice.
    Sii-Felice K; Giorgi M; Leboulch P; Payen E
    Exp Hematol; 2018 Aug; 64():12-32. PubMed ID: 29807062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular therapies in beta-thalassaemia.
    Quek L; Thein SL
    Br J Haematol; 2007 Feb; 136(3):353-65. PubMed ID: 17129232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Editing an α-globin enhancer in primary human hematopoietic stem cells as a treatment for β-thalassemia.
    Mettananda S; Fisher CA; Hay D; Badat M; Quek L; Clark K; Hublitz P; Downes D; Kerry J; Gosden M; Telenius J; Sloane-Stanley JA; Faustino P; Coelho A; Doondeea J; Usukhbayar B; Sopp P; Sharpe JA; Hughes JR; Vyas P; Gibbons RJ; Higgs DR
    Nat Commun; 2017 Sep; 8(1):424. PubMed ID: 28871148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hurdles to the Adoption of Gene Therapy as a Curative Option for Transfusion-Dependent Thalassemia.
    Thuret I; Ruggeri A; Angelucci E; Chabannon C
    Stem Cells Transl Med; 2022 Apr; 11(4):407-414. PubMed ID: 35267028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New therapeutic targets in transfusion-dependent and -independent thalassemia.
    Cappellini MD; Motta I
    Hematology Am Soc Hematol Educ Program; 2017 Dec; 2017(1):278-283. PubMed ID: 29222267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.